United Therapeutics Corporation (NASDAQ:UTHR) Q1 2025 Earnings Call Transcript April 30, 2025
United Therapeutics Corporation beats earnings expectations. Reported EPS is $6.63, expectations were $6.29.
Operator: Good morning and welcome to the United Therapeutics Corporation First Quarter 2025 Corporate Update. My name is Dorwin [ph] and I will be your conference operator today. All participants on the call portion of this webcast will be in listen-only mode until the question-and-answer...
